Reducing the variability of DLCO measurements in clinical trials
A. Hagberg (Gothenburg, Sweden), J. Betts (Gothenburg, Sweden), C. Kristensson (Gothenburg, Sweden), J. Mo (Gothenburg, Sweden), S. Asimus (Gothenburg, Sweden), M. Sadiq (Gothenburg, Sweden), T. Koernicke (Berlin, Germany), R. Fuhr (Berlin, Germany), W. Brailsford (Gothenburg, Sweden), C. Keen (Gothenburg, Sweden), J. Mäenpää (Gothenburg, Sweden)
Source: International Congress 2019 – Physiologic assessment of airway diseases
Session: Physiologic assessment of airway diseases
Session type: Thematic Poster
Number: 2650
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hagberg (Gothenburg, Sweden), J. Betts (Gothenburg, Sweden), C. Kristensson (Gothenburg, Sweden), J. Mo (Gothenburg, Sweden), S. Asimus (Gothenburg, Sweden), M. Sadiq (Gothenburg, Sweden), T. Koernicke (Berlin, Germany), R. Fuhr (Berlin, Germany), W. Brailsford (Gothenburg, Sweden), C. Keen (Gothenburg, Sweden), J. Mäenpää (Gothenburg, Sweden). Reducing the variability of DLCO measurements in clinical trials. 2650
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
DLco simulations for qualification of DLco devices globally for inhaled levodopa clinical trials. Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
COPDGene intra-subject variability of DLco measurements using an ultrasound-based instrument Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015
Measuring bronchodilation in COPD clinical trials Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004
Correlations of ventilation heterogeneity and spirometry in asthma; initial experience with hyperpolarised gas MRI in a clinical setting. Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019 Year: 2019
Reproducibility of measurements of inspiratory capacity, dyspnea intensity and exercise endurance in multicentre trials in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 323s Year: 2004
Duration and frequency of spirometry needed to accurately reflect longitudinal change of FEV1 in COPD Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021
Prevalence of altering selected spirometry maneuvers in asthma clinical trials. Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021
Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018
Quality control of DL,CO instruments in global clinical trials Source: Eur Respir J 2009; 33: 828-834 Year: 2009
When is FEV1 loss excessive? – an investigation of the relationship between year-to-year and long-term spirometry changes Source: Annual Congress 2004 - Longitudinal studies and determinants of lung function and COPD Year: 2004
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Pooled clinical trial analysis of the rate of decline in FEV1 according to perceived dyspnea and health status Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008
Clinical relevance of constant power exercise duration changes in COPD Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance Year: 2009
Pattern of diffusion disturbance related to clinical diagnosis: the KCO has no additional diagnostic value next to the DLCO Source: Eur Respir J 2005; 26: Suppl. 49, 523s Year: 2005
The clinical value of bodybox measurements Source: International Congress 2015 – CC5 Interpretation of pulmonary function testing Year: 2015
DLCO biological controls in clinical practice. Source: International Congress 2019 – Quality, performance and interpretation of lung function testing Year: 2019
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
FEV6 : a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
D LCO : adjust for lung volume, standardised reporting and interpretationSource: Eur Respir J, 50 (2) 1700940; 10.1183/13993003.00940-2017 Year: 2017
D LCO : adjust for lung volume, standardised reporting and interpretationSource: Eur Respir J, 50 (2) 1701144; 10.1183/13993003.01144-2017 Year: 2017